All In MedTech

Device Trial Radar · NCT04782050

Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation

Diagnostic échographique Non-invasif Des Maladies Chroniques du Foie en Consultation d'hépatologie

Last checked: Nov 20, 2026Latest source record: Apr 25, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

100

Actual

Start

Sep 15, 2021

Primary completion

Aug 29, 2022

Study completion Aug 29, 2022

Sponsor

Lead sponsor
E-ScopicsNot on our public-company list
Sponsor type
Industry
Collaborators
University Hospital, Bordeaux
First posted
Mar 4, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Early screening and monitoring of chronic liver diseases in hepatology practice has become crucial. To achieve this goal, hepatology clinics need simple and available tools at the point-of-care to perform disease severity assessment. The objective of this study is to assess the performance of a new non-invasive ultrasound-based system for the assessment of liver fibrosis and steatosis severity, via ultrasound biomarkers such as tissue stiffness (correlated to fibrosis severity) and ultrasound tissue attenuation (correlated to steatosis extent).

Conditions

  • Liver Diseases
  • Liver Cirrhosis
  • Non-Alcoholic Fatty Liver Disease

Interventions

  • Ultrasound liver assessmentDevice

    The intervention consists in an ultrasound exam performed with the ultrasound medical device subject of the research.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Correlation of biomarkers to existing biomarker referencesTime frame: At study completion, 1 year
  2. Diagnostic performance of biomarkers in researchTime frame: At study completion, 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Bordeaux University Hospital

    Pessac, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.